CoChat

Low Doses of Dexamethasone Can Produce a Hypocorticosteroid State in the Brain

Karssen, A. M., Meijer, O. C., Berry, A., Sanjuan Piñol, R., de Kloet, E. R. · 2005 · Endocrinology
Cited by 104

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

The synthetic glucocorticoid dexamethasone (dex) blocks stress-induced hypothalamic-pituitary-adrenal (HPA) activation primarily at the level of the anterior pituitary because multidrug resistance P-glycoprotein hampers its penetration in the brain. Here, we tested the hypothesis that central components of the HPA axis would escape dex suppression under conditions of potent peripheral glucocorticoid action. We subchronically treated rats with low or high doses of dex. The animals were subjected on the last day of treatment for 30 min to a restraint stressor after which central and peripheral markers of HPA axis activity were measured. Basal and stress-induced corticosterone secretion, body weight gain, adrenal and thymus weight, as well as proopiomelanocortin mRNA in the anterior pituitary were reduced in a dose-dependent manner by dex administered either 5 d sc or 3 wk orally. In the brain, the highest dose dex suppressed CRH mRNA and CRH heteronuclear RNA in the paraventricular nucleus (PVN). However, in the peripherally active low-dose range of dex CRH mRNA and heteronuclear RNA showed resistance to suppression, and CRH mRNA expression in the PVN was in fact enhanced under the long-term treatment condition. In the PVN, c-fos mRNA was suppressed by the highest dose of dex, but this effect showed a degree of resistance after long-term oral treatment. c-fos mRNA responses in the anterior pituitary followed those in PVN and reflect central drive of the HPA axis even if corticosterone responses are strongly reduced. The results support the concept that low doses of dex can create a hypocorticoid state in the brain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2005-0501

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 46

  1. Reul, 2000, The brain mineralocorticoid receptor: greedy for ligand, mysterious in function., Eur J Pharmacol, 405, 235, 10.1016/S0014-2999(00)00677-4 · DOI · Paper page
  2. De Kloet, 1974, The site of suppressive action of dexamethasone on pituitary-adrenal activity., Endocrinology, 94, 61, 10.1210/endo-94-1-61 · DOI · Paper page
  3. Miller, 1992, Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test., Biol Psychiatry, 32, 850, 10.1016/0006-3223(92)90175-Y · DOI
  4. Cole, 2000, Dexamethasone suppression of corticosteroid secretion: evaluation of the site of action by receptor measures and functional studies., Psychoneuroendocrinology, 25, 151, 10.1016/S0306-4530(99)00045-1 · DOI · Paper page
  5. Cordon-Cardo, 1989, Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites., Proc Natl Acad Sci USA, 86, 695, 10.1073/pnas.86.2.695 · DOI · Paper page
  6. Schinkel, 1995, Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A., J Clin Invest, 96, 1698, 10.1172/JCI118214 · DOI · Paper page
  7. Meijer, 1998, Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1a P-glycoprotein knockout mice., Endocrinology, 139, 1789, 10.1210/endo.139.4.5917 · doi:10.1210/endo.139.4.5917 · Paper page
  8. Ginsberg, 2003, Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus., J Neuroendocrinol, 15, 1075, 10.1046/j.1365-2826.2003.01100.x · DOI · Paper page
  9. Fluttert, 2000, A refined method for sequential blood sampling by tail incision in rats., Lab Anim, 34, 372, 10.1258/002367700780387714 · DOI · Paper page
  10. Sibug, 1998, Flesinoxan treatment reduces 5-HT1A receptor mRNA in the dentate gyrus independently of high plasma corticosterone levels., Eur J Pharmacol, 353, 207, 10.1016/S0014-2999(98)00417-8 · DOI
  11. Veldhuis, 1982, Specificity of adrenal steroid receptor system in the rat hippocampus., Endocrinology, 110, 2044, 10.1210/endo-110-6-2044 · DOI · Paper page
  12. Harbuz, 1989, Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat., J Endocrinol, 122, 705, 10.1677/joe.0.1220705 · DOI · Paper page
  13. Senba, 1994, Differential expression of fos family and jun family mRNAs in the rat hypothalamo-pituitary-adrenal axis after immobilization stress., Brain Res Mol Brain Res, 24, 283, 10.1016/0169-328X(94)90141-4 · DOI
  14. Stumpf, 1989, Dexamethasone and corticosterone receptor sites. Differential topographic distribution in rat hippocampus revealed by high resolution autoradiography., Histochemistry, 92, 201, 10.1007/BF00500919 · DOI
  15. Karssen, 2001, Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain., Endocrinology, 142, 2686, 10.1210/endo.142.6.8213 · doi:10.1210/endo.142.6.8213 · Paper page
  16. McEwen, 1976, Interactions in vivo and in vitro of corticoids and progesterone with cell nuclei and soluble macromolecules from rat brain regions and pituitary., Brain Res, 105, 129, 10.1016/0006-8993(76)90928-8 · DOI
  17. Coutard, 1978, Tissue distribution and specific binding of tritiated dexamethasone in vivo: autoradiographic and cell fractionation studies in the mouse., Endocrinology, 103, 1144, 10.1210/endo-103-4-1144 · DOI
  18. Karssen, 2002, The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone., J Endocrinol, 175, 251, 10.1677/joe.0.1750251 · DOI · Paper page
  19. Uhr, 2002, Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins., J Neuroendocrinol, 14, 753, 10.1046/j.1365-2826.2002.00836.x · DOI · Paper page
  20. Miller, 1990, Adrenal steroid receptor binding in spleen and thymus after stress or dexamethasone, Am J Physiol, 259, E405
  21. Kovacs, 1987, Dexamethasone inhibits corticotropin-releasing factor gene expression in the rat paraventricular nucleus., Neuroendocrinology, 46, 365, 10.1159/000124846 · DOI · Paper page
  22. Imaki, 1995, Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoids in rats., J Clin Invest, 96, 231, 10.1172/JCI118026 · DOI · Paper page
  23. Roozendaal, 1996, The memory-modulatory effects of glucocorticoids depend on an intact stria terminalis., Brain Res, 709, 243, 10.1016/0006-8993(95)01305-9 · DOI
  24. Feldman, 2002, Further evidence for the central effect of dexamethasone at the hypothalamic level in the negative feedback mechanism., Brain Res, 958, 291, 10.1016/S0006-8993(02)03581-3 · DOI
  25. Gass, 2000, Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice., EMBO Rep, 1, 447, 10.1093/embo-reports/kvd088 · DOI · Paper page
  26. Sloviter, 1989, Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy., Science, 243, 535, 10.1126/science.2911756 · DOI · Paper page
  27. Hornsby, 1996, Dexamethasone does not prevent seven-day ADX-induced apoptosis in the dentate gyrus of the rat hippocampus., Stress, 1, 51, 10.3109/10253899609001095 · DOI · Paper page
  28. Hassan, 1996, Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone., Exp Neurol, 140, 43, 10.1006/exnr.1996.0113 · DOI · Paper page
  29. De Kloet, 1991, Brain corticosteroid receptor balance and homeostatic control., Front Neuroendocrinol, 12, 95
  30. Laugero, 2002, Corticosterone infused intracerebroventricularly inhibits energy storage and stimulates the hypothalamo-pituitary axis in adrenalectomized rats drinking sucrose., Endocrinology, 143, 4552, 10.1210/en.2002-220613 · DOI · Paper page
  31. Laugero, 2001, Sucrose ingestion normalizes central expression of corticotropin-releasing-factor messenger ribonucleic acid and energy balance in adrenalectomized rats: a glucocorticoid-metabolic-brain axis?, Endocrinology, 142, 2796, 10.1210/endo.142.7.8250 · doi:10.1210/endo.142.7.8250 · Paper page
  32. Oitzl, 1992, Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning., Behav Neurosci, 106, 62, 10.1037/0735-7044.106.1.62 · DOI · Paper page
  33. Sandi, 1998, The role and mechanisms of action of glucocorticoid involvement in memory storage., Neural Plast, 6, 41, 10.1155/NP.1998.41 · DOI · Paper page
  34. Herman, 1992, Rapid regulation of corticotropin-releasing hormone gene transcription in vivo., Mol Endocrinol, 6, 1061
  35. Melia, 1994, Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress., J Neurosci, 14, 5929, 10.1523/JNEUROSCI.14-10-05929.1994 · DOI · Paper page
  36. Helmreich, 1996, The effect of adrenalectomy on stress-induced c-fos mRNA expression in the rat brain., Brain Res, 706, 137, 10.1016/0006-8993(95)01215-X · DOI
  37. Brown, 1997, Hypophysiotropic CRF neurons display a sustained immediate-early gene response to chronic stress but not to adrenalectomy., J Neuroendocrinol, 9, 307, 10.1046/j.1365-2826.1997.00586.x · DOI · Paper page
  38. Malkoski, 1997, Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene., Mol Cell Endocrinol, 127, 189, 10.1016/S0303-7207(96)04004-X · DOI
  39. Autelitano, 1994, Glucocorticoid regulation of c-fos, c-jun and transcription factor AP-1 in the AtT-20 corticotrope cell., J Neuroendocrinology, 6, 627, 10.1111/j.1365-2826.1994.tb00629.x · DOI
  40. Holsboer, 1996, Antidepressants and hypothalamo-pituitary-adrenal regulation., Endocr Rev, 17, 187, 10.1210/edrv-17-2-187 · DOI · Paper page
  41. Holsboer, 2000, The corticosteroid receptor hypothesis of depression., Neuropsychopharmacology, 23, 477, 10.1016/S0893-133X(00)00159-7 · DOI · Paper page
  42. Bardeleben, 1985, Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects., Life Sci, 37, 1613, 10.1016/0024-3205(85)90480-1 · DOI
  43. Mei, 2004, Using real-time quantitative TaqMan RT-PCR to evaluate the role of dexamethasone in gene regulation of rat P-glycoproteins mdr1a/1b and cytochrome P450 3A1/2., J Pharm Sci, 93, 2488, 10.1002/jps.20102 · doi:10.1002/jps.20102
  44. Kwan, 2003, Differential expression of multidrug resistance genes in naive rat brain., Neurosci Lett, 339, 33, 10.1016/S0304-3940(02)01453-2 · DOI
  45. Dallman, 1987, Regulation of ACTH secretion: variations on a theme of B., Recent Prog Horm Res, 43, 113
  46. Dallman, 1994, Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis., Ann N Y Acad Sci, 746, 22, 10.1111/j.1749-6632.1994.tb39206.x · DOI · Paper page

Cited by

See all 104

Metadata

Authors
Karssen, A. M., Meijer, O. C., Berry, A., Sanjuan Piñol, R., & de Kloet, E. R.
Venue
Endocrinology
Published
2005-12-01
Volume
146
Issue
12
Pages
5587-5595
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W1992060542
Cited by
104
References
11
FWCI
2.16
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.